Tate group members participated in the inaugural Chemistry at The Crick Symposium, where Dr. Zhangping Xiao received the People’s Choice Poster Prize
The inaugural Chemistry at The Crick Symposium, themed "Bridging Chemistry and Biology: Driving Discovery and Innovation at the Crick" brought together chemistry and biology group leaders alongside STP leads at the Crick. The event showcased the critical role of chemistry in addressing complex biological questions, highlighting cutting-edge research and fostering interdisciplinary collaborations that underscore chemistry’s essential contributions to the life sciences.
Members of the Tate lab played a key role in organizing and participating in the symposium. Prof. Ed Tate delivered a keynote lecture, reflecting on a two-decade-long project in the Tate group—the development and translation of NMT inhibitors—culminating in over £100 million in investment and the successful Imperial spin-out company, Myricx Bio.
The symposium also provided a platform for early-career researchers to present their work through several poster sessions. Dr. Zhangping Xiao from the Tate lab showcased our latest progress in targeted protein degradation with a poster presentation titled "Identification of Actionable Targeted Protein Degradation Effector Sites through Site-Specific Ligand Incorporation-Induced Proximity (SLIP)." His poster was recognized with the People’s Choice Poster Prize, celebrating this innovative research.
Article text (excluding photos or graphics) © Imperial College London.
Photos and graphics subject to third party copyright used with permission or © Imperial College London.
Reporter
Edward Bartlett
Department of Chemistry
